|
rs7085104
|
AS3MT;BORCS7-ASMT
|
Schizophrenia
|
A |
0.800 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
|
30285260 |
2019 |
|
rs12244388
|
AS3MT;BORCS7-ASMT
|
Schizophrenia
|
|
0.700 |
GeneticVariation |
GWASCAT |
Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association Study.
|
31268507 |
2019 |
|
rs12764899
|
AS3MT;BORCS7-ASMT
|
Intelligence
|
|
0.700 |
GeneticVariation |
GWASCAT |
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.
|
31374203 |
2019 |
|
rs12764899
|
AS3MT;BORCS7-ASMT
|
RDW - Red blood cell distribution width result
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
rs12764899
|
AS3MT;BORCS7-ASMT
|
Red cell distribution width determination
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
rs12764899
|
AS3MT;BORCS7-ASMT
|
Schizophrenia
|
|
0.700 |
GeneticVariation |
GWASCAT |
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.
|
31374203 |
2019 |
|
rs12765002
|
AS3MT;BORCS7-ASMT
|
Body mass index
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
rs72841270
|
AS3MT;BORCS7-ASMT
|
Body Height
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
rs77335224
|
AS3MT;BORCS7-ASMT
|
Body mass index
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
|
30239722 |
2019 |
|
rs10748835
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Acute Promyelocytic Leukemia
|
|
0.010 |
GeneticVariation |
BEFREE |
Our data promotes the realization that AS3MT 35587 (rs11191453), 35991 (rs10748835), especially their joint genotypes 35991 (rs10748835) AA / 35587 (rs11191453) TC+CC, is a novel predictive biomarker for the therapeutic efficacy of As<sub>2</sub>O<sub>3</sub> in the treatment of APL.
|
31330140 |
2019 |
|
rs11191453
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Acute Promyelocytic Leukemia
|
|
0.010 |
GeneticVariation |
BEFREE |
Our data promotes the realization that AS3MT 35587 (rs11191453), 35991 (rs10748835), especially their joint genotypes 35991 (rs10748835) AA / 35587 (rs11191453) TC+CC, is a novel predictive biomarker for the therapeutic efficacy of As<sub>2</sub>O<sub>3</sub> in the treatment of APL.
|
31330140 |
2019 |
|
rs11191454
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Autistic Disorder
|
|
0.010 |
GeneticVariation |
BEFREE |
Therefore, this family-based association study was performed in 640 Chinese Han autism trios to investigate the association between autism and 7 SNPs with genome-wide significance in previous GWAS (rs4307059 near MSNP1AS, rs4141463 in MACROD2, rs2535629 in ITIH3, rs11191454 in AS3MT, rs1625579 in MIR137HG, rs11191580 in NT5C2, and rs1409313 in CUEDC2).
|
30610940 |
2019 |
|
rs12765002
|
AS3MT;BORCS7-ASMT
|
Anxiety
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways.
|
29942085 |
2018 |
|
rs3740390
|
AS3MT;BORCS7-ASMT
|
Coronary Artery Disease
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease.
|
29212778 |
2018 |
|
rs3740393
|
AS3MT;BORCS7-ASMT
|
Anxiety
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways.
|
29942085 |
2018 |
|
rs7909591
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Alcohol consumption
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
|
29912962 |
2018 |
|
rs7909591
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Systolic Pressure
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
|
29912962 |
2018 |
|
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Carcinoma of bladder
|
|
0.020 |
GeneticVariation |
BEFREE |
The polymorphisms of AS3MT rs11191438, AS3MT rs10748835, and AS3MT rs1046778 were related to the risk of BC and UTUC, while the polymorphisms of AS3MT rs3740393, AS3MT rs11191453, and AS3MT rs11191454 were associated with arsenic methylation capacity.
|
29859237 |
2018 |
|
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Malignant neoplasm of urinary bladder
|
|
0.020 |
GeneticVariation |
BEFREE |
The polymorphisms of AS3MT rs11191438, AS3MT rs10748835, and AS3MT rs1046778 were related to the risk of BC and UTUC, while the polymorphisms of AS3MT rs3740393, AS3MT rs11191453, and AS3MT rs11191454 were associated with arsenic methylation capacity.
|
29859237 |
2018 |
|
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Malignant neoplasm of urinary bladder
|
|
0.020 |
GeneticVariation |
BEFREE |
High MMA%, low DMA% and AS3MT rs1046778 C/C + C/T genotype predicted a significantly higher risk of BC according to stepwise multiple logistic regression analyses.
|
29669044 |
2018 |
|
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Carcinoma of bladder
|
|
0.020 |
GeneticVariation |
BEFREE |
High MMA%, low DMA% and AS3MT rs1046778 C/C + C/T genotype predicted a significantly higher risk of BC according to stepwise multiple logistic regression analyses.
|
29669044 |
2018 |
|
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Bladder Neoplasm
|
|
0.020 |
GeneticVariation |
BEFREE |
The polymorphisms of AS3MT rs11191438, AS3MT rs10748835, and AS3MT rs1046778 were related to the risk of BC and UTUC, while the polymorphisms of AS3MT rs3740393, AS3MT rs11191453, and AS3MT rs11191454 were associated with arsenic methylation capacity.
|
29859237 |
2018 |
|
rs1046778
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Bladder Neoplasm
|
|
0.020 |
GeneticVariation |
BEFREE |
High MMA%, low DMA% and AS3MT rs1046778 C/C + C/T genotype predicted a significantly higher risk of BC according to stepwise multiple logistic regression analyses.
|
29669044 |
2018 |
|
rs10748835
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Malignant neoplasm of urinary bladder
|
|
0.020 |
GeneticVariation |
BEFREE |
The combination of AS3MT haplotype 2 (AS3MT rs11191453, rs11191454, rs10748835, and rs1046778)'s high-risk haplotype (C-G-A-C, T-A-A-C, and T-G-G-T) was significantly associated with increased risk of BC.
|
29669044 |
2018 |
|
rs10748835
|
AS3MT;BORCS7-ASMT;LOC107984265
|
Bladder Neoplasm
|
|
0.020 |
GeneticVariation |
BEFREE |
The polymorphisms of AS3MT rs11191438, AS3MT rs10748835, and AS3MT rs1046778 were related to the risk of BC and UTUC, while the polymorphisms of AS3MT rs3740393, AS3MT rs11191453, and AS3MT rs11191454 were associated with arsenic methylation capacity.
|
29859237 |
2018 |